Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling

20 Jul 2020

Abstract excerpt

Abstract Background The emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a looming threat to human health. Although there are numerous studies regarding porin alteration in association with the production of ESBLs and/or AmpC β-lactamase, a systematic study on the treatment-emergence of porins alteration in antibiotic resistance does not yet exist. The aim of this study was to investigate the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Bacterial Genetics and Biotechnology
Share to Pneumonia and Respiratory Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32689945
DOI: 10.1186/s12866-020-01898-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodelingPMID 32689945Read ↗

First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling.Semantic proximity Read ↗

Emergence of Ceftazidime/Avibactam and Tigecycline Resistance in Carbapenem-Resistant Klebsiella pneumoniae Due to In-Host MicroevolutionSemantic proximity Read ↗

Stepwise evolution of carbapenem-resistance, captured in patient samples and evident in global genomics of <i>Klebsiella pneumoniae</i>Semantic proximity Read ↗

Molecular Characterization of Klebsiella pneumoniae Clinical Isolates with Elevated Resistance to CarbapenemsSemantic proximity Read ↗

Emerging Resistance to Novel -βLactam β-Lactamase Inhibitor Combinations in Klebsiella pneumoniae bearing KPC VariantsSemantic proximity Read ↗

In-vivo loss of carbapenem resistance by extensively drug-resistant Klebsiella pneumoniae during treatment via porin expression modification.Semantic proximity Read ↗

A large-scale surveillance revealed that KPC variants mediated ceftazidime-avibactam resistance in clinically isolated Klebsiella pneumoniae.Semantic proximity Read ↗

Emergence of carbapenem, beta-lactamase inhibitor and cefoxitin resistant lineages from a background of ESBL-producing <i>Klebsiella pneumoniae</i> and <i>K. quasipneumoniae</i> highlights different evolutionary mechanismsSemantic proximity Read ↗

In vivo adaptive antimicrobial resistance in Klebsiella pneumoniae during antibiotic therapySemantic proximity Read ↗

Resistance to carbapenems in sequence type 11 Klebsiella pneumoniae is related to DHA-1 and loss of OmpK35 and/or OmpK36.Semantic proximity Read ↗

Antibiotic pressure on the acquisition and loss of antibiotic resistance genes in Klebsiella pneumoniaeSemantic proximity Read ↗

Klebsiella pneumoniae Carbapenemases in Enterobacteriaceae: History, Evolution, and Microbiology ConcernsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.